KPV

KPV works by targeting the body’s inflammatory signaling pathways, helping bring an overactive immune response back under control without shutting the system down completely.

→ Melanocortin receptor activity KPV is thought to act primarily through MC1R and MC3R receptors, which are expressed on immune cells and tissues involved in inflammation. Activation of these receptors reduces the release of pro-inflammatory molecules like TNF-α, IL-1β, and IL-6.

→ NF-κB pathway inhibition One of KPV’s most studied effects is its ability to block NF-κB activation, a master regulator of inflammation. By calming this pathway, KPV reduces the cascade of inflammatory cytokines that fuel chronic pain, gut inflammation, and tissue breakdown.

→ Barrier protection In gut models, KPV helps reinforce epithelial barrier integrity, preventing “leaky gut” scenarios where toxins and microbes cross into circulation and drive systemic inflammation.